A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer

BACKGROUND: Colon cancer (CRC) was a malignant tumor and there were about 25% of patients with tumor metastasis at diagnosis stage. Chemotherapeutic agents for metastatic CRC patients were with great side effects and the clinical treatment results of advanced CRC were still not satisfactory. Human e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalikong, Ayimukedisi, Li, Xu-Quan, Zhou, Ping-Hong, Qi, Zhi-Peng, Li, Bing, Cai, Shi-Lun, Zhong, Yun-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989962/
https://www.ncbi.nlm.nih.gov/pubmed/33776436
http://dx.doi.org/10.2147/IJN.S287732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989962/
https://www.ncbi.nlm.nih.gov/pubmed/33776436
http://dx.doi.org/10.2147/IJN.S287732

Ejemplares similares